Taflan SUD is manufactured with USA technology from Weiler, as well as European-sourced resin pellets, ensuring the optimum quality of the product. Taflan SUD ensures a high degree of product sterility assurance. It is manufactured in a Re-closable vial, ensures convenience & less wastage, while daily use; thus, reduces unnecessary costs at a time. It is a selective FP prostanoid receptor agonist that reduces intraocular pressure by increasing uveoscleral outflow, as well as to a lesser degree through the trabecular outflow pathway. It increases ocular blood flow and thus provides neuroprotective action. Taflan SUD shows a lower incidence of Conjunctival hyperemia & Iris pigmentation than other prostaglandin Analogues.
© 2024. Aristopharma Ltd. All rights reserved.